These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38105274)
61. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071 [TBL] [Abstract][Full Text] [Related]
62. Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment. Youn H; Lee S; Han C; Kim SH; Jeong HG Int J Geriatr Psychiatry; 2019 Dec; 34(12):1907-1915. PubMed ID: 31489705 [TBL] [Abstract][Full Text] [Related]
63. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537 [TBL] [Abstract][Full Text] [Related]
64. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349 [TBL] [Abstract][Full Text] [Related]
65. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment. Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417 [TBL] [Abstract][Full Text] [Related]
66. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S; Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118 [TBL] [Abstract][Full Text] [Related]
67. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers. Ota K; Oishi N; Ito K; Fukuyama H; ; J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727 [TBL] [Abstract][Full Text] [Related]
68. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
69. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]
70. Amnestic multiple cognitive domains impairment and periventricular white matter hyperintensities are independently predictive factors progression to dementia in mild cognitive impairment. Lee HK; Lee YM; Park JM; Lee BD; Moon ES; Chung YI Int J Geriatr Psychiatry; 2014 May; 29(5):526-32. PubMed ID: 24123391 [TBL] [Abstract][Full Text] [Related]
71. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study. Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329 [TBL] [Abstract][Full Text] [Related]
72. Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI. Ezzati A; Zammit AR; Habeck C; Hall CB; Lipton RB; Brain Imaging Behav; 2020 Oct; 14(5):1792-1804. PubMed ID: 31104279 [TBL] [Abstract][Full Text] [Related]
73. A biomarker study in long-lasting amnestic mild cognitive impairment. Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292 [TBL] [Abstract][Full Text] [Related]
74. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease. Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926 [TBL] [Abstract][Full Text] [Related]
75. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Prasad K; Wiryasaputra L; Ng A; Kandiah N Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908 [TBL] [Abstract][Full Text] [Related]
80. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment. Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]